KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Invested Capital (2016 - 2025)

Historic Invested Capital for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $2.0 billion.

  • Idexx Laboratories' Invested Capital rose 792.97% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 792.97%. This contributed to the annual value of $2.2 billion for FY2024, which is 139.27% up from last year.
  • Per Idexx Laboratories' latest filing, its Invested Capital stood at $2.0 billion for Q3 2025, which was up 792.97% from $2.0 billion recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Invested Capital registered a high of $2.2 billion during Q4 2024, and its lowest value of $828.4 million during Q1 2021.
  • Its 5-year average for Invested Capital is $1.5 billion, with a median of $1.5 billion in 2021.
  • As far as peak fluctuations go, Idexx Laboratories' Invested Capital skyrocketed by 12106.68% in 2021, and later tumbled by 1052.71% in 2022.
  • Over the past 5 years, Idexx Laboratories' Invested Capital (Quarter) stood at $1.5 billion in 2021, then fell by 10.53% to $1.4 billion in 2022, then skyrocketed by 58.34% to $2.2 billion in 2023, then rose by 1.39% to $2.2 billion in 2024, then decreased by 8.9% to $2.0 billion in 2025.
  • Its last three reported values are $2.0 billion in Q3 2025, $2.0 billion for Q2 2025, and $1.8 billion during Q1 2025.